Serine/threonine-protein kinase B-raf (586-614)

Serine/threonine-protein kinase B-raf (586-614) is a synthetic peptide fragment corresponding to amino acids 586 through 614 of the B-raf protein, a critical serine/threonine kinase in the RAF/MEK/ERK signaling pathway. This peptide segment encompasses a region implicated in the regulatory and functional dynamics of B-raf, a protein well-known for its involvement in cell proliferation, differentiation, and survival signaling. As a research tool, the peptide offers valuable insight into the structural and functional aspects of the B-raf kinase domain, supporting a range of biochemical investigations targeting kinase activity, protein-protein interactions, and post-translational modifications.

Kinase substrate studies: The peptide serves as a defined substrate for in vitro kinase assays, enabling researchers to evaluate the phosphorylation activity of kinases that target the B-raf sequence. By providing a precise and consistent substrate, it facilitates quantitative assessment of kinase function, inhibitor screening, and comparative studies of phosphorylation efficiency. This application is particularly relevant for dissecting the specificity and kinetics of serine/threonine kinases acting on B-raf and related signaling molecules.

Protein-protein interaction analysis: As a representative segment of B-raf, the peptide is frequently employed in binding assays to map interaction sites with regulatory proteins, scaffolding molecules, or other components of the MAPK pathway. Utilizing the peptide in pull-down experiments, surface plasmon resonance, or fluorescence-based assays allows for the identification and characterization of binding partners that modulate B-raf activity or localization, thereby advancing the understanding of signaling network dynamics.

Epitope mapping and antibody validation: The defined sequence of the peptide makes it an ideal tool for epitope mapping studies and for validating the specificity of antibodies directed against B-raf. By employing the peptide in immunoassays such as ELISA or western blotting, researchers can confirm antibody binding to the intended region, optimize antibody production, and ensure reliable detection of B-raf in complex biological samples.

Phosphorylation site characterization: The peptide is valuable for investigating post-translational modifications, particularly phosphorylation events within the B-raf protein. When subjected to in vitro phosphorylation by kinases, the peptide can be analyzed through mass spectrometry or phospho-specific antibodies to pinpoint modification sites, quantify phosphorylation stoichiometry, and study the regulatory impact of these modifications on B-raf function.

Peptide-based inhibitor screening: The sequence provides a platform for screening and characterizing small-molecule inhibitors or peptide antagonists that target B-raf or its interaction motifs. By incorporating the peptide into competitive binding or enzymatic inhibition assays, researchers can evaluate the efficacy, selectivity, and mechanism of candidate compounds, supporting drug discovery efforts focused on modulating kinase-driven signaling pathways.

1. Immune responses to homocitrulline-and citrulline-containing peptides in rheumatoid arthritis

2. Relatedness of antibodies to peptides containing homocitrulline or citrulline in patients with rheumatoid arthritis

3. Identification, Localization in the Central Nervous System and Novel Myostimulatory Effect of Allatostatins in Tenebrio molitor Beetle

4. Cationic cell-penetrating peptides are potent furin inhibitors

5. Immune-awakening Saccharomyces-inspired nanocarrier for oral target delivery to lymph and tumors